Nafri Tablets (Nafronil Oxalate)

Adult dose

Administer 100 mg of nafronyl oxalate orally 3 times daily.

This medication should not be used in patients with acute myocardial infarction or in the early stages of bleeding injuries. Patients with orthostatic dysregulation or a history of allergic reactions to this medication should also not take it. It is contraindicated for patients with hyperoxaluria or recurrent calcium kidney stones, as well as those with acute heart failure or congestive heart failure. Patients with cardiac conduction defects, angina, severe hypotension, liver function issues, or those at risk of seizures should not be treated with this drug. Pregnant women, those who may become pregnant, and nursing mothers are advised not to use this medication. It should be used cautiously in patients with impaired kidney function or coronary artery disease. Neurogenic symptoms such as convulsions, anxiety, drowsiness, headaches, and dizziness may occur while taking this medication. Gastrointestinal issues such as loss of appetite, vomiting, and diarrhea may also happen. Allergic reactions such as hives or rashes should be monitored. Liver function anomalies may lead to hepatitis or jaundice, and there is a risk of developing kidney stones. Cardiovascular symptoms such as hypotension, arrhythmias, angina, syncope, and edema have also been reported. Blood sugar levels may increase, so individuals requiring blood sugar monitoring should exercise caution. This medication is not used for hypertension treatment and sufficient water should be consumed to prevent kidney stones. Taking this medication without beverage before sleep may lead to esophagitis; thus, it must be taken with water. If taken together with antihypertensives or antiarrhythmics, the effects may be enhanced, so consultation with a healthcare provider is necessary. Women who are pregnant or breastfeeding should avoid this medication. In case of overdose, cardiac rhythm may be suppressed, or seizures may occur, necessitating immediate medical attention. Treatment includes gastric lavage, administration of activated charcoal, and monitoring of cardiac and respiratory function; severe cases may require specialized treatment.

• Brain convulsions
• sensory abnormalities
• anxiety
• drowsiness
• insomnia
• fatigue
• headache
• dizziness
• loss of appetite
• esophagitis

Store this medication in a tightly closed container that can block light, and keep it in a temperature range between 1°C and 30°C.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle